Losartan withdrawal effects
Pro Research Analysisby 
Searched over 200M research papers
Losartan Withdrawal Effects: Safety, Tolerability, and Blood Pressure Response
Safety and Tolerability of Losartan Withdrawal
Clinical studies show that losartan is generally well-tolerated, with a low rate of withdrawal due to adverse effects. Importantly, when patients stop taking losartan, there is no evidence of withdrawal effects such as rebound hypertension or other clinically significant problems. The rate of withdrawal due to adverse experiences is actually lower for losartan than for placebo, and no unexpected laboratory abnormalities have been observed after stopping the drug. This suggests that losartan can be discontinued without causing significant withdrawal symptoms or safety concerns in most patients Goldberg1995Goldberg1995.
Blood Pressure and Organ Effects After Losartan Discontinuation
Research in animal models indicates that the antihypertensive effects of losartan do not persist after the drug is stopped. In studies comparing losartan to other antihypertensive agents, blood pressure and cardiac hypertrophy quickly return to pre-treatment levels after losartan withdrawal, indicating that its beneficial effects are not sustained without ongoing therapy . This is in contrast to some other antihypertensive drugs, such as aliskiren or early ACE inhibitor therapy, which may have more persistent effects even after discontinuation Naelten2005Rakušan2010.
Losartan and Ethanol Withdrawal: Protective Effects
In the context of ethanol withdrawal, losartan has been shown to prevent increases in blood pressure and vascular oxidative stress that are otherwise triggered by withdrawal. These protective effects are due to losartan’s ability to block angiotensin II type 1 (AT1) receptors, which play a key role in the harmful cardiovascular changes seen during ethanol withdrawal. However, these findings relate to losartan’s use during ethanol withdrawal, not to withdrawal from losartan itself Gonzaga2018Assis2019.
Conclusion
Stopping losartan does not cause rebound hypertension or other significant withdrawal effects in clinical settings. Its antihypertensive and organ-protective benefits do not persist after discontinuation, so ongoing therapy is needed for continued effect. In special situations like ethanol withdrawal, losartan can help prevent harmful cardiovascular changes, but there is no evidence that stopping losartan itself causes withdrawal symptoms or adverse effects Goldberg1995Naelten2005Rakušan2010+1 MORE.
Sources and full results
Most relevant research papers on this topic
Ethanol withdrawal increases blood pressure and vascular oxidative stress: a role for angiotensin type 1 receptors.
Ethanol withdrawal increases blood pressure and vascular oxidative stress through angiotensin type 1 receptor-dependent mechanisms.
Ethanol Withdrawal Alters the Oxidative State of the Heart Through AT1-Dependent Mechanisms.
Ethanol withdrawal alters the cardiac oxidative state through AT1-dependent mechanisms, with angiotensin II/AT1 receptors playing a role in the initial steps of these cardiac effects.
Efficacy and safety of losartan.
Losartan is an effective and well-tolerated antihypertensive agent, with a smooth antihypertensive profile and similar effects to other drugs, with dizziness being the most common adverse experience.
Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.
Losartan has beneficial effects on liver fibrosis and splanchnic hemodynamics in BDL and CCl 4 rats, but higher dosages may have deleterious effects in BDL rats.
Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients.
Losartan acts as an immunomodulator that prevents the development of CD14+CD16+ pro-inflammatory monocytes in haemodialysis patients.
DOI